ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection

Clinical trial NCT07513285 · RECRUITING

Trial details

NCT number: NCT07513285
Sponsor: Acurx Pharmaceuticals Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Clostridium Difficile Infection Recurrence

Start date: 2026-08-06
Primary completion: 2027-09-29
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.